Discover 1,461 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,461
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
for
Parkinson Disease
Location: Seattle WA, Bellevue WA, Portland OR, Los Angeles CA,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 40 - 70+
Code: NCT06976268
Phase 2, Phase 3, Recruiting
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
for
Major Depressive Disorder
Location: Bellevue WA, Walnut Creek CA, San Jose CA, Orem UT,
Sponsor: Autobahn Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06633016
Phase 2, Recruiting
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
for
Attention Deficit Disorder With Hyperactivity (ADHD)
Location: Bellevue WA, Las Vegas NV, Chino CA, Lincoln NE,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 65
Code: NCT07755410
Phase 2, Recruiting
Randomized Withdrawal Study in Patients With Schizophrenia
for
Schizophrenia
Location: Bellevue WA, Walnut Creek CA, Las Vegas NV,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT06961968
Phase 3, Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
for
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: Cytokinetics
Sex: All
Age: 40 - 70+
Code: NCT06793371
Phase 2, Recruiting
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis (gMG)
Location: Seattle WA, Portland OR, Sacramento CA,
Sponsor: Cabaletta Bio
Sex: All
Age: 18 - 70
Code: NCT06359041
Phase 1, Phase 2, Recruiting
EffectiveNess and SAfety of Small ANeurysm COiling Trial
for
Aneurysm
Location: Seattle WA, Saskatoon, Santa Barbara CA, Englewood CO,
Sponsor: University of Virginia
Sex: All
Age: 18 - 70+
Code: NCT02167997
Recruiting
New
Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation
for
Atrial Fibrillation
Location: Bellevue WA, Jonesboro AR
Sponsor: Kardium Inc.
Sex: All
Age: 18+
Code: NCT07651852
Recruiting
FORWARD CAD IDE Study
for
Coronary Arterial Disease (CAD)
Location: Bellevue WA, Seattle WA, Portland OR, San Francisco CA,
Sponsor: Shockwave Medical, Inc.
Sex: All
Age: 18+
Code: NCT06662500
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for
Coronary Arterial Disease (CAD),
Location: Bellevue WA, Portland OR, San Francisco CA, Stanford CA,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06959524
Recruiting
New
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
for
Colon Cancer
Location: Seattle WA, Los Angeles CA, Cleveland OH
Sponsor: Solstice Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07808151
Phase 2, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Seattle WA, Tacoma WA, Olympia WA, Salem OR, Spokane WA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: Dianthus Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06858579
Phase 3, Recruiting
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Seattle WA, Edmonds WA, San Francisco CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05850234
Phase 1, Phase 2, Recruiting
Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone
for
Substance-Related Disorders
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18 - 40
Code: NCT00504413
Phase 1, Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Seattle WA, Edmonds WA, Los Angeles CA, Winnipeg,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05061550
Phase 2, Recruiting
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
for
B-cell Malignancies
Location: Seattle WA, Calgary, La Jolla CA, Rochester MN,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06542250
Phase 1, Phase 2, Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis